Relmada Therapeutics, Inc. (RLMD): 8-K filed May 12, 2026

Form type

8-K

Filing date

May 12, 2026

Accession number

0001213900-26-055164

Filer

Relmada Therapeutics, Inc. (CIK 1553643)